Nuvation Bio (NUVB) Prepaid Assets (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Prepaid Assets of $16.0 million for Q1 2026, up 89.8% year-over-year from $8.4 million in Q1 2025, and up 38.45% quarter-over-quarter from $11.5 million in Q4 2025.
Nuvation Bio (NUVB) Prepaid Assets (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Prepaid Assets for 7 consecutive years, with $16.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 89.8% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $16.0 million (up 89.8% YoY), while the FY2025 annual figure was $11.5 million, up 58.66% from the prior year.
- Prepaid Assets improved to $16.0 million in Q1 2026 per NUVB's latest filing, from $11.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $16.0 million in Q1 2026 and bottomed at $1.5 million in Q4 2023.
- Historically, Prepaid Assets has averaged $7.1 million across 5 years, with a median of $7.3 million in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 60.23% — and 2024, when it soared 378.67%.
- Nuvation Bio's Prepaid Assets stood at $3.8 million in 2022, then slumped by 60.23% to $1.5 million in 2023, then surged by 378.67% to $7.3 million in 2024, then soared by 58.66% to $11.5 million in 2025, then jumped by 38.45% to $16.0 million in 2026.
- Business Quant data shows NUVB's Prepaid Assets at $16.0 million in Q1 2026, $11.5 million in Q4 2025, and $8.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.86 Mn |
| Mar 31, 2026 | 15.97 Mn |
| Dec 31, 2025 | 11.54 Mn |
| Sep 30, 2025 | 8.93 Mn |
| Jun 30, 2025 | 8.26 Mn |
| Mar 31, 2025 | 8.42 Mn |
| Dec 31, 2024 | 7.27 Mn |
| Sep 30, 2024 | 11.60 Mn |
| Jun 30, 2024 | 5.99 Mn |
| Mar 31, 2024 | 6.80 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 2.98 Mn |
| Jun 30, 2023 | 3.53 Mn |
| Mar 31, 2023 | 3.68 Mn |
| Dec 31, 2022 | 3.82 Mn |
| Sep 30, 2022 | 5.09 Mn |
| Jun 30, 2022 | 7.80 Mn |
| Mar 31, 2022 | 7.84 Mn |
| Dec 31, 2021 | 3.64 Mn |
| Sep 30, 2021 | 3.01 Mn |